Accession Number: | 0001209191-22-037412 |
Date: | 2022-06-14 |
Issuer: | ARCUS BIOSCIENCES, INC. (RCUS) |
Original Submission Date: |
LACEY DAVID L.
C/O ARCUS BIOSCIENCES, INC.
3928 POINT EDEN WAY
HAYWARD, CA 94545
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-06-14 | A | 4,100 | a | $0.00 | 42,452 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 20.62 | 2022-06-14 | deemed execution date | A | 16,800 (a) | 2032-06-13 | common stock 16,800 | $20.62 | 16,800 | direct |
ID | footnote |
---|---|
f1 | represents the grant of restricted stock units that vest in full on the earlier of june 14, 2023 or the next annual meeting of stockholders of the issuer. the rsus will become fully vested in the event the company is subject to a change in control. |
f2 | includes 3,000 shares of restricted stock units (previously reported) that vested on june 3, 2022. |
f3 | the option will vest in full on the earlier of june 14, 2023 or the next annual meeting of stockholders of the issuer. the option will become fully vested and exercisable in the event the company is subject to a change in control. |